Procillin 300 mg/ml Suspension for Injection for Cattle, Sheep and Pigs Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

procillin 300 mg/ml suspension for injection for cattle, sheep and pigs

bimeda animal health limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin

Dipen 100ml Suspension for Injection for cattle, sheep and pigs Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

dipen 100ml suspension for injection for cattle, sheep and pigs

bimeda animal health limited - procaine benzylpenicillin; dihydrostreptomycin sulfate - suspension for injection - 200, 200 milligram(s)/millilitre - penicillins, combinations with other antibacterials

Bimoxyl LA 150 mg/ml Suspension for Injection Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

bimoxyl la 150 mg/ml suspension for injection

bimeda animal health limited - amoxicillin trihydrate - suspension for injection - 150 milligram(s)/millilitre - amoxicillin

Ultrapen LA 300 mg/ml Suspension for Injection Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

ultrapen la 300 mg/ml suspension for injection

norbrook laboratories (ireland) limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin

Norocillin 300 mg/ml Suspension for Injection Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

norocillin 300 mg/ml suspension for injection

norbrook laboratories (ireland) limited - procaine benzylpenicillin - suspension for injection - 300 milligram(s)/millilitre - benzylpenicillin

INVEGA HAFYERA paliperidone (as palmitate) 1000 mg in 5 mL modified release suspension for injection pre-filled syringe Australia - Inggris - Department of Health (Therapeutic Goods Administration)

invega hafyera paliperidone (as palmitate) 1000 mg in 5 ml modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 1560 mg - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - invega hafyera, a 6-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months or the 3-month paliperidone palmitate injectable product following at least one 3-month injection cycle.

INVEGA HAFYERA paliperidone (as palmitate) 700 mg in 3.5 mL modified release suspension for injection pre-filled syringe Australia - Inggris - Department of Health (Therapeutic Goods Administration)

invega hafyera paliperidone (as palmitate) 700 mg in 3.5 ml modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 1092 mg - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - invega hafyera, a 6-month injection, is indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months or the 3-month paliperidone palmitate injectable product following at least one 3-month injection cycle.

TRUMENBA (Meningococcal group B vaccine) suspension for injection pre-filled syringe Australia - Inggris - Department of Health (Therapeutic Goods Administration)

trumenba (meningococcal group b vaccine) suspension for injection pre-filled syringe

pfizer australia pty ltd - neisseria meningitidis serogroup b recombinant lipidated- factor h binding protein subfamily a, quantity: 60 microgram; neisseria meningitidis serogroup b recombinant lipidated- factor h binding protein subfamily b, quantity: 60 microgram - injection, suspension - excipient ingredients: water for injections; aluminium phosphate; histidine; sodium chloride; polysorbate 80 - trumenba is indicated in individuals 10 years and older for active immunisation to prevent invasive meningococcal disease caused by neisseria meningitidis serogroup b.

INVEGA TRINZA paliperidone (as palmitate) 525 mg modified release suspension for injection pre-filled syringe Australia - Inggris - Department of Health (Therapeutic Goods Administration)

invega trinza paliperidone (as palmitate) 525 mg modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.

INVEGA TRINZA paliperidone (as palmitate) 350 mg modified release suspension for injection pre-filled syringe Australia - Inggris - Department of Health (Therapeutic Goods Administration)

invega trinza paliperidone (as palmitate) 350 mg modified release suspension for injection pre-filled syringe

janssen-cilag pty ltd - paliperidone palmitate, quantity: 312 mg/ml (equivalent: paliperidone, qty 200 mg/ml) - injection, suspension - excipient ingredients: polysorbate 20; macrogol 4000; citric acid monohydrate; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - indicated for the maintenance treatment of schizophrenia in adult patients who have been adequately treated with the 1-month paliperidone palmitate injectable product for at least four months.